Catalio Capital

United States

Firm Location:United States • Massachusetts • New York, New York • Los Angeles, California • Houston, Texas • San Diego, California • San Francisco, California • Boston, Massachusetts • Baltimore, Maryland • Sacramento, California • Fairfield, California • Cambridge, Massachusetts • Boulder, Colorado • Weston, Florida • Bethesda • Stanford, California • New York City • United Kingdom

Investor Firms That Co-Invest with Catalio Capital

Abingworth Flagship Ventures Illumina Ventures Petri Angel investor What If Ventures ARCH Venture Partners Third Rock Ventures Hatteras Venture Partners Andreessen Horowitz Nexus Venture Partners Vivo Capital Kurma Partners Inveready Technology Investment Group MPM Capital Polaris Partners Presight Capital EQT Life Sciences Dimension Capital

Catalio Capital Team

INVESTORS	INTRO STRENGTH	SWEET SPOT (RANGE)	INVESTMENT LOCATIONS	TOP INVESTMENT CATEGORIES
Leslie A. Leinwand Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Denver (CO), Investors in Boulder (CO)	Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in Colorado / Utah (Other Lists), Investors in Consumer Health (Seed) +2
João Amorim Catalio CapitalAnalyst	n/a	$1.5M ($100K - $5.0M)	Investors in Boston (MA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +9
Michael A. Rogawski Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Sacramento (CA)	Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A) +2
Alan Ashworth Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in San Francisco (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +9
Holly Barra Catalio CapitalAnalyst	n/a	$1.5M ($100K - $5.0M)	Investors in Baltimore (MD), Investors in Rockville (MD), Investors in Washington (D.C.), Investors in New York (NY)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists) +10
Regina Barzilay Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Boston (MA), Investors in Cambridge (MA)	Investors in Data Services (Seed), Investors in Data Services (Series A), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Series A), Investors in Data Services (Seed), Investors in AI (Series A), Investors in Data Services (Series A), Investors in Boston / New England (Other Lists) +4
Benjamin Bell Catalio CapitalAnalyst	n/a	$1.5M ($100K - $5.0M)	Investors in Boston (MA), Investors in Baltimore (MD)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +16
Henry Brem Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Boston (MA), Investors in Baltimore (MD)	Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A) +9
George C. Petrocheilos Catalio CapitalManaging Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Baltimore (MD), Investors in Athens (Greece), Investors in New York (NY)	Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Robotics (Series B), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Robotics (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Robotics (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Washington, D.C. (Other Lists), Investors in Cybersecurity (Seed), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series A), Investors in Diagnostics (Series B), Investors in Cybersecurity (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Seed), Investors in Cybersecurity (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed) +52
Thomas C. Südhof Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Stanford (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +9
Eugene de Juan Jr Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in SF Bay Area (CA), Investors in San Francisco (CA)	Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A) +5
Titia de Lange Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in San Francisco (CA)	Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A) +1
Philip D. Greenberg Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in New York (NY), Investors in United States	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +9
Christine E. 'Kricket' Seidman Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in SF Bay Area (CA), Investors in San Francisco (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +9
Napoleone Ferrara Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in San Diego (CA)	Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Los Angeles / Southern California (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A) +2
Jenna Glatzer Catalio CapitalAnalyst	n/a	$1.5M ($100K - $5.0M)	Investors in Rochester (NY), Investors in Baltimore (MD)	Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Washington, D.C. (Other Lists) +4
Nicholas von Guionneau Catalio CapitalAnalyst	n/a	$1.5M ($100K - $5.0M)	Investors in United Kingdom	Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed)
Justin Hanes Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Boston (MA), Investors in Waltham (MA), Investors in Baltimore (MD)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A) +16
Frances H. Arnold Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in San Diego (CA), Investors in Santa Monica (CA), Investors in Los Angeles (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Chemicals (Series A), Investors in Chemicals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Chemicals (Seed), Investors in BioTech (Series A), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Series A) +9
Matthew Hobson Catalio CapitalAnalyst	n/a	$1.5M ($100K - $5.0M)	Investors in Baltimore (MD)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +9
Solomon H. Snyder Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Baltimore (MD)	Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists) +2
Jim J. Collins Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in New York (NY)	Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series B) +3
Jeffrey Karp Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Boston (MA)	Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A) +5
Raju Kucherlapati Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Boston (MA), Investors in Weston (FL)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +16
Freda Lewis-Hall Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in New York (NY)	Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +21
Dan Littman Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in New York (NY)	Investors in BioTech (Series B), Investors in New York City (Other Lists), Investors in BioTech (Series B)
Nathan Livingston Catalio CapitalAnalyst	n/a	$1.5M ($100K - $5.0M)	Investors in Baltimore (MD)	Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in Semiconductors (Seed), Investors in Semiconductors (Series A), Investors in Washington, D.C. (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed) +5
Gregg L. Semenza Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Baltimore (MD)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +9
Lauren Maslin Catalio CapitalAnalyst	n/a	$1.5M ($100K - $5.0M)	Investors in New York City, Investors in Baltimore (MD)	Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Washington, D.C. (Other Lists) +4
George M. Church Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in SF Bay Area (CA), Investors in Cambridge (MA), Investors in Boston (MA)	Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed) +7
Jeffrey M. Friedman Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in New York City	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +9
Samir Mitragotri Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Santa Barbara (CA), Investors in Boston (MA), Investors in Cambridge (MA)	Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A) +5
Drew M. Pardoll Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Baltimore (MD)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +9
Sangeeta N. Bhatia Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Massachusetts, Investors in San Diego (CA), Investors in Cambridge (MA)	Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A) +16
William R. Brody Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Philadelphia (PA), Investors in San Francisco (CA)	Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A) +10
Adam Riess Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in New York (NY)	Investors in Data Services (Seed), Investors in Data Services (Series A), Investors in Space (Series A), Investors in Space (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Series A), Investors in Data Services (Seed), Investors in New York City (Other Lists), Investors in Space (Seed), Investors in AI (Series A), Investors in Data Services (Series A), Investors in Space (Series A) +8
Josh Samuelson Catalio CapitalAdvisor	n/a	$1.5M ($100K - $5.0M)	Investors in Fairfield (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +9
Joan S. Brugge Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Boston (MA)	Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists) +1
Padmanee 'Pam' Sharma Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Houston (TX)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Austin (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +9
David Sinclair Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Cambridge (MA), Investors in Sydney (Australia), Investors in SF Bay Area (CA), Investors in Boston (MA)	Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Boston / New England (Other Lists) +10
Maria Sirenko Catalio CapitalAnalyst	n/a	$1.5M ($100K - $5.0M)	Investors in New York City	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +9
Barbara Slusher Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Baltimore (MD)	Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists) +2
Paula T. Hammond Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Cambridge (MA), Investors in Massachusetts	Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A) +1
C. Giovanni Traverso Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Boston (MA), Investors in Cambridge (MA)	Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A) +1
Tom V. Brooks Catalio CapitalGeneral Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Denver (CO), Investors in Baltimore (MD)	Investors in Pharmaceuticals (Seed), Investors in EnergyTech (Seed), Investors in EnergyTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in EnergyTech (Seed), Investors in EnergyTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in EnergyTech (Series A), Investors in EnergyTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Colorado / Utah (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +22
R. Jacob Vogelstein Catalio CapitalManaging Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Washington (D.C.), Investors in Baltimore (MD), Investors in Bethesda	Investors in AI (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Medical Devices (Series B), Investors in Washington, D.C. (Other Lists), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B) +17
Bert Vogelstein Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Cambridge (MA), Investors in Boston (MA), Investors in Baltimore (MD)	Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed) +9
Gordana Vunjak-Novakovic Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in New York (NY)	Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in BioTech (Series A) +1
Diamantis Xylas Catalio CapitalAnalyst	n/a	$1.5M ($100K - $5.0M)	Investors in London, Investors in Baltimore (MD), Investors in New York (NY)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in London (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed) +23
Elias Zerhouni Catalio CapitalVenture Partner	n/a	$1.5M ($100K - $5.0M)	Investors in Baltimore (MD)	Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed) +10